Start here

Opzelura changed what I can offer people with vitiligo — it is the first cream approved for repigmenting, and on the face it works well enough that I raise it at the first visit. Most of the conversation is about patience: six months before we judge anything, a year before we know what we have, and the face responds far better than hands and feet. The other part is the boxed warning — serious infections, heart events, blood clots, cancer — which comes from tablets in this class at full doses in older people with rheumatoid arthritis, not from the cream trials. The limits are real: no more than one in five of your body surface at a time, no more than one 60-gram tube a week, and cost is what most often decides it.

— Dr. Schwarz, Board Certified Dermatologist

Key Facts

−

Also called	Opzelura
Drug class	Topical JAK inhibitor (blocks JAK1 and JAK2)
Applied as	1.5% cream
Approved for	Nonsegmental vitiligo and mild to moderate eczema, age 12 and up
Typical course	Eczema, short and on-and-off. Vitiligo, at least 6 months and often much longer
Time to work	Eczema, itch within days and clearing over 4 to 8 weeks. Vitiligo, months
Prescription only	Yes

What It Is

−

Ruxolitinib cream is a prescription anti-inflammatory. It was approved in the United States in 2021 for short-term, on-and-off treatment of mild to moderate eczema in people aged 12 and up who are not immunocompromised, and in 2022 for nonsegmental vitiligo in the same age group. The vitiligo approval was the first of its kind. Until then no drug had been approved anywhere to restore lost pigment. Ruxolitinib itself is not new — it has been a tablet for years in certain bone marrow disorders. The cream delivers the same molecule into the skin at doses that keep blood levels very low. Approved uses are expanding, so ask what it is licensed for where you live. Brand only. No generic.

How It Works

−

Immune signaling chemicals called cytokines land on receptors on the outside of a cell. To pass the message inward, the receptor uses enzymes called Janus kinases, or JAKs. Block a JAK and the message never reaches the nucleus, so the cell does not switch on.

Ruxolitinib blocks two of them, JAK1 and JAK2, shutting down a large group of inflammatory signals at once. That is why it works quickly and in more than one condition.

In eczema it blocks the signals that drive itch directly, so itch often improves within a day or two, well before the rash looks better.

Vitiligo happens when the immune system destroys melanocytes, the cells that make pigment. The attack runs on a cytokine called interferon-gamma, which signals through JAK1 and JAK2. Blocking that pathway calls off the attack, so surviving melanocytes, mostly the ones in hair follicles, move back into the skin and make pigment again. That is why repigmentation often appears first as small dots around hairs.

It does not thin skin the way steroids do, so it can go on the face and eyelids, which is where vitiligo is most visible.

Here is where Ruxolitinib Cream (Opzelura) acts in the skin, and what the others do instead.

About Ruxolitinib Cream (Opzelura)

Compare

Skin basics

The redness, swelling and itch are the immune system reacting, not the damage itself. Ruxolitinib Cream (Opzelura) turns that reaction down where it is happening, in the skin, which is why a rash settles within days. Blocks JAK, the relay carrying the itch signal, so itch settles fast. Unlike a steroid there is a cap on how much and how long.

Ruxolitinib crosses the barrier well, and enough can reach the blood that there is a limit on how much you may use in a week.

In a plaque, skin cells travel from the bottom of the epidermis to the surface in four to six days instead of a month, and pile up as scale. This slows them back down, so the plaque thins.

The outer film of dead cells and oil. It holds water in and keeps irritants out, and it is thinner than a sheet of paper. Almost every dry, itchy, stinging skin problem starts here.

The outer layer, and the only one anything in a jar reaches. It renews itself constantly: a cell made at the bottom takes about a month to reach the surface and flake off. Most of what a skincare product does, it does here.

The living layer underneath, holding the blood vessels, the nerves and the collagen. It is where lasting change happens and it is hard to reach: most of what is sold for the skin never gets this far.

What It Treats

−

Vitiligo

Strong evidence

A JAK inhibitor cream approved specifically to restore pigment in vitiligo, applied twice a day. In trials about a third of people had most of the color back on the face by six months, and results keep improving past a year. It is slow, it is expensive, and color can be lost again if it is stopped, so it is usually continued about twice a week afterwards.

Eczema

Strong evidence

A newer steroid-free cream that takes the itch down quickly. It is meant for short courses on a limited area of the body, and it carries the warnings that come with the JAK class.

Not the Best For

−

Vitiligo on hands, feet, wrists and ankles

Doesn't work

Repigmentation here is slow, patchy and often incomplete, because there is little hair and the surviving pigment cells live in hair follicles. Worth knowing before you start.

Continuous long-term use for eczema

Doesn't work

For eczema it is approved for short intermittent courses rather than continuous use, and the label says to stop and reconsider if the skin is not clear by week eight.

Forms

−

One form only:

No other forms or strengths:

The 60-gram tube size is not incidental:

Strengths

−

One strength only.

The only strength

1.5%

Nothing weaker to start on, nothing stronger to step up to. If it is not working, the adjustment is time and consistency — and for vitiligo, adding light treatment.

Basics

−

When to Apply

A thin layer twice a day, roughly twelve hours apart, on affected skin only. Wash your hands afterwards unless your hands are being treated. Two limits are on the label, not suggestions: no more than 20% of your body surface at a time, and no more than 60 grams a week, or 100 grams over two weeks. One palm is about 1% of your body surface.

How to Start

Twice daily from day one. For eczema, keep going until the skin is clear, then stop — the label calls it short-term, on-and-off treatment. For vitiligo it is the opposite: use it steadily. Stopping early is the usual reason it appears not to work.

If It Irritates

Redness, itch or a mild sting where you apply it is the usual early complaint and it settles. Acne or small bumps at the site is the other common one, most often on the face in vitiligo treatment, and it is treatable rather than a reason to stop. Moisturizing afterwards helps both.

If It's Not Working

For eczema, reassess at 8 weeks; if the skin is not clear, the label says stop and reconsider. For vitiligo, do not judge before 24 weeks. Repigmentation is slow, it starts on the face, and hands and feet may show very little for a long time. No change by about six months is when your doctor will usually add narrowband UVB light treatment.

Sample Routine

−

Here is where Ruxolitinib Cream (Opzelura) sits in a day, and what goes around it. Pick what you are treating and what your skin is like, and the rest of the routine changes to suit.

Routine forSkin type

What to Expect

−

First few minutes | Applying it

A thin layer twice a day. Mild stinging or redness where you apply it is the usual side effect.

Days 1 to 7 | Adjusting

For eczema, itch often improves within the first few days, sometimes the first day — among the quickest of any topical. For vitiligo, nothing visible yet.

Weeks 2 to 4 | Working, eczema

Redness fades and the rash flattens. Most of the eczema improvement happens here.

Weeks 4 to 8 | Judge it here, eczema

Week 8 is the fair point. If the skin is not clear, the label says stop and reconsider.

Weeks 8 to 24 | Working, vitiligo

The first sign is small pigmented dots inside a patch, often around hairs, which spread and join up. The face and neck move first, and around a third of people reach 75 percent repigmentation of the face by about six months.

Months 6 to 12 and beyond | Continuing, vitiligo

By about a year roughly half reach that 75 percent mark on the face. The trunk and limbs are slower, and skin with hair does better, because surviving pigment cells live in hair follicles. Where vitiligo is still spreading, the cream helps hold the line.

Throughout | Watch for

Acne or small bumps at the site. Report any fever, unusual infection, chest pain, breathlessness or swollen painful leg.

What to Avoid

−

Going over the area limit No more than 20% of your body surface at a time. One palm is roughly 1%, so 20% is about twenty palms' worth. More raises how much reaches your bloodstream.
Going over the amount limit No more than 60 grams a week, or 100 grams over two weeks. If you run out faster, tell your doctor rather than stretch the dose.
Continuous use for eczema without review The label describes short courses — different from vitiligo, where steady long-term use is the point.
Applying it to infected skin Treat cold sores, impetigo, shingles or a fungal rash first. Calming the local immune response over an untreated infection lets it spread.
Covering it with an airtight dressing Occlusion increases absorption.
Live vaccines while using it Plan this with your doctor. Routine non-live vaccines, including most flu shots, are not the concern.
Expecting sunscreen to be optional Newly repigmented skin and unpigmented patches both burn easily.

Monitoring

−

For most healthy people using it within the label limits, no routine blood tests are needed. Blood levels from the cream are very low, and the trials did not find the blood count or cholesterol changes the tablet causes.

Your doctor monitors the label's safety concerns by asking rather than testing. Expect questions about blood clots, heart attack or stroke, smoking, cancer, tuberculosis exposure, hepatitis, and whether anything else you take suppresses your immune system. This cream is not meant to be combined with other JAK inhibitors, biologics or strong immunosuppressants.

They will check the response on schedule — 8 weeks for eczema, 24 weeks and then longer for vitiligo — and ask about infections, unexplained fever, night sweats, weight loss, chest pain, breathlessness and leg swelling. Some doctors check blood counts and cholesterol at baseline in people with other risk factors.

Skin checks matter for a different reason — unpigmented skin burns easily, so an annual look at the skin is sensible regardless.

If You Stop

−

There is no taper and no withdrawal effect. You can stop on any day. With eczema, the rash generally comes back over days to weeks, because the drug treats the inflammation and not the underlying tendency. The treatment is designed to be used in courses. Vitiligo is different. Pigment that has come back tends to stay. What can return is the immune attack, so patches may start losing color again, and in trials many people who stopped lost ground over the following months. So vitiligo treatment is usually continued long term, or tapered slowly under supervision.

Cost

−

Cost is the honest sticking point. Ruxolitinib cream is brand only with no generic, and a 60-gram tube lists at a few thousand dollars. Since a tube is one week's maximum, sustained use is expensive at list price. Almost nobody pays that, but almost everybody has to work for coverage. A prior authorization is standard. For eczema, plans typically want a topical steroid and often a calcineurin inhibitor tried first. For vitiligo, coverage has been harder because some plans treat it as cosmetic — a letter from your dermatologist explaining that vitiligo is an autoimmune disease with real medical and psychological effects is usually what turns that around. Denials are frequently overturned on appeal. The manufacturer runs a copay program that can cut the cost a lot with commercial insurance, plus patient assistance for people who qualify. Terms change often. People on government insurance are usually not eligible for copay cards, which is a real gap. One practical point: the drug is priced by the tube, so treating only the areas that need it is a cost decision as well as a safety rule.

Ask Your Doctor

−

If you are pregnant or breastfeeding

this includes planning a pregnancy. Ask the doctor managing your pregnancy before starting or continuing. Keep it off the breast and nipple while breastfeeding.

If you have had a blood clot or stroke

a heart attack, or smoking, counts too. These are the boxed warning risks, and they change how the decision is weighed.

If you have had cancer

including skin cancer. Discuss it before starting.

If you have had tuberculosis or hepatitis

hepatitis B and C count, and so does being around someone with active tuberculosis. Your doctor may want testing first.

If you take another JAK inhibitor

a biologic or a strong immunosuppressant counts too. The label advises against combining these.

If your immune system is weakened

by a transplant, chemotherapy, HIV or long-term immune-suppressing treatment, this cream is not approved for the eczema use.

If you develop a fever or night sweats

unusual tiredness, or an infection that will not clear, counts too. Report it rather than wait.

If you get chest pain or breathlessness

one-sided weakness, slurred speech, or a swollen painful leg counts too. Seek urgent care.

If you need a live vaccine

plan the timing with your doctor.

If you need more than one tube a week

say so, rather than rationing or quietly exceeding the limit.

How It Compares

−

Topical steroids

Worse

decades of evidence, cheap and fast for eczema, and used off-label for vitiligo. The trade-off is skin thinning with long use, which matters most on the face — exactly where vitiligo is most visible and where treatment is needed longest.

Tacrolimus ointment and pimecrolimus cream

Worse

well established for eczema, used off-label for vitiligo, and both avoid skin thinning. They are far cheaper, especially now that generics exist. For vitiligo the evidence is weaker than for ruxolitinib cream and repigmentation is generally slower, though tacrolimus with light treatment has a long track record.

Narrowband UVB light treatment

The same

the most established vitiligo treatment there is, and the combination of light plus a cream generally beats either alone. The trade-off is practical — it usually means two or three clinic visits a week for months.

Roflumilast cream

Different job

once daily, no boxed warning, no limit on how much skin you treat, and good evidence in psoriasis and eczema. It is not a vitiligo treatment, which is the main dividing line between the two.

A white and green autoinjector pen labeled Dupixent lying on a plain pale background

Dupilumab

Different job

an injection for moderate to severe eczema, much stronger for widespread disease and used continuously. Different scale of treatment, different cost structure, and not a vitiligo drug.

Where ruxolitinib cream fits

Better

It rests on one thing no other topical can claim. It is approved to bring pigment back in vitiligo. For eczema alone, several cheaper options do a similar job with fewer restrictions.

Myths

"It is the same as taking a JAK pill." Same molecule, very different exposure. Tablets are absorbed throughout the body at full doses. A cream within the label limits produces a small fraction of that, and the skin trials did not show the blood count, cholesterol or infection changes seen with tablets.
"The boxed warning means the cream causes heart attacks and cancer." The warning is class labeling. It came from a large safety study of an oral JAK inhibitor in people over 50 with rheumatoid arthritis and existing heart risk factors, and regulators applied it to the whole class. The cream's own trials did not show those events. It describes a risk established in a different medicine, at a different dose, in a different population.
"Vitiligo cannot be treated." It can, and this cream is the first one approved to restore pigment. It does not work for everyone and it is slow, but the old advice that nothing could be done is out of date.
"If the face repigments, everything will." No. The face and neck respond best because they have the most hair follicles. Hands, feet, wrists and ankles are slowest and often least complete.
"You can just use it everywhere since it is only a cream." The 20% body surface and 60 grams a week limits are what keep blood levels low.
"Once the color is back you are done." Pigment usually stays, but the immune attack can restart, so treatment is generally continued or reduced gradually with supervision.

Questions Patients Ask

How long before I see color coming back?

Most people see the first small pigmented dots between two and six months, usually on the face and often around hairs. Twenty-four weeks is the earliest fair point to judge, and results keep improving past a year.

Why is there a boxed warning on a cream?

Regulators applied it to the whole drug class after a large safety study of a JAK tablet in older people with rheumatoid arthritis and heart risk factors found more heart events, clots, infections and cancers. The cream's own trials did not show those events, and blood levels from a cream within the limits are a small fraction of a tablet dose.

Why can I only treat 20% of my body?

That limit and the 60 grams a week cap keep the amount reaching your bloodstream low. It is why the safety picture for the cream differs from the tablet.

Will the pigment stay if I stop?

Pigment that has returned usually stays, but the immune attack can restart and patches can begin losing color again. Most people continue treatment or reduce it gradually rather than stopping outright.

Why am I getting spots where I put it on?

Acne at the application site is a recognized side effect, most often on the face during vitiligo treatment. It is treatable and not a reason to stop.

Does it work on hands and feet?

Less well, and more slowly. Areas with few hair follicles have fewer surviving pigment cells to repopulate the skin. The face is where this cream does its best work.

Can I use it with light treatment?

A common combination, often more effective than either alone, but plan it with your dermatologist rather than starting on your own.

Ruxolitinib Cream (Opzelura)